Parkinson’s Disease Treatment Market – Global Forecast to 2022
The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at a CAGR of 6.1% from 2017 to 2022 to reach USD 5.69 billion in 2022. The carbidopa/levodopa drug class is projected to register highest CAGR during forecast period. The major driving factors for this market include ageing population and government funding for research, growing healthcare awareness. ...
Parkinson’s Disease Treatment Market by Patient Care Setting
The major driving factors for this Parkinson’s Disease Treatment Market include ageing population and government funding for research, growing healthcare awareness.
The base year considered for the study is 2016, and the forecast has been provided for the period between 2018 and 2023.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247
Hospital
Hospitals...